-
Maternal serum resistin at 11 to 13 weeks' gestation in normal and pathological pregnancies.
Nanda S, Poon LC, Muhaisen M, Acosta IC, Nicolaides KH.
Metabolism 2012;61:699-705. -
Maternal hemodynamics at 11-13 weeks' gestation in gestational diabetes mellitus.
Khalil A, Garcia-Mandujano R, Chiriac R, Akolekar R, Nicolaides KH.
Fetal Diagn Ther 2012;31:216-20. -
Body Mass Index at 11-13 Weeks' Gestation and Pregnancy Complications.
Syngelaki A, Bredaki FE, Vaikousi E, Maiz N, Nicolaides KH.
Fetal Diagn Ther 2011;30:250-65. -
Maternal serum 25-hydroxyvitamin D levels at 11(+0) -13(+6) weeks in pregnant women with diabetes mellitus and in those with macrosomic neonates.
Savvidou M, Akolekar R, Samaha R, Masconi A, Nicolaides Kh.
BJOG 2011;118:951-5. -
Criteria for screening and diagnosis of gestational diabetes mellitus in the first trimester of pregnancy.
Plasencia W, Garcia R, Pereira S, Akolekar R, Nicolaides KH.
Fetal Diagn Ther 2011;30:108-15. -
A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment.
Nicolaides KH.
Prenat Diagn 2011;31:3-6. -
Turning the pyramid of prenatal care.
Nicolaides KH.
Fetal Diagn Ther 2011;29:183-96. -
Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks.
Nanda S, Savvidou M, Syngelaki A, Akolekar R, Nicolaides KH.
Prenat Diagn 2011;31:135-41. -
First-trimester circulating 25-hydroxyvitamin d levels and development of gestational diabetes mellitus.
Makgoba M, Nelson SM, Savvidou M, Messow CM, Nicolaides K, Sattar N.
Diabetes Care 2011;34:1091-3. -
Feasibility of DNA diagnosis of haemoglobinopathies on coelocentesis.
Giambona A, Makrydimas G, Leto F, Damiani G, Jakil MC, Picciotto F, Renda D, Fiorino R, Renda MC, Schillaci G, Gueli-Alletti D, Nicolaides KH, Maggio A.
Br J Haematol 2011;153:268-72. -
Maternal serum visfatin at 11-13 Weeks of gestation in gestational diabetes mellitus.
Ferreira AF, Rezende JC, Vaikousi E, Akolekar R, Nicolaides KH.
Clin Chem 2011;57:609-13. -
Maternal arterial stiffness in pregnancies complicated by gestational and type 2 diabetes mellitus.
Savvidou MD, Anderson JM, Kaihura C, Nicolaides KH.
Am J Obstet Gynecol 2010;203:274. -
First trimester prediction of gestational diabetes: examining the potential of combining maternal characteristics and laboratory measures.
Savvidou M, Nelson SM, Makgoba M, Messow CM, Sattar N, Nicolaides K.
Diabetes 2010;59:3017-22. -
Maternal arterial stiffness in pregnancies affected by Type 1 diabetes mellitus.
Anderson JM, Savvidou MD, Kaihura C, McEniery CM, Nicolaides KH.
Diabet Med 2009;26:1135-40. -
Some thoughts on the true value of ultrasound.
Nicolaides KH.
Ultrasound Obstet Gynecol 2007;30:671-4. -
Cell-free DNA levels in pregnancies at risk of sickle-cell disease and significant ethnic variation.
Gerovassili A, Nicolaides KH, Thein SL, Rees DC.
Br J Haematol 2006;135:738-41. -
Maternal serum level of placental growth factor in diabetic pregnancies.
Ong CY, Lao TT, Spencer K, Nicolaides KH.
J Reprod Med 2004;49:477-80. -
Fetal and embryonic hemoglobins in erythroblasts from fetal blood and fetal cells enriched from maternal blood in pregnancies complicated by maternal diabetes mellitus.
Al-Mufti R, Hambley H, Farzaneh F, Nicolaides KH.
J Matern Fetal Neonatal Med 2004;15:109-14. -
Impaired vascular reactivity in pregnant women with insulin-dependent diabetes mellitus.
Savvidou MD, Geerts L, Nicolaides KH.
Am J Obstet Gynecol 2002;186:84-8. -
Mass spectral analysis of asymmetric hemoglobin hybrids: demonstration of Hb FS alpha2gammabetaS) in sickle cell disease.
Ofori-Acquah SF, Green BN, Davies SC, Nicolaides KH, Serjeant GR, Layton DM.
Anal Biochem 2001;298:76-82.